
Ticasign Tablet
Marketer
HAB Pharma
Salt Composition
Ticagrelor (90mg)
Overview Ticasign Tablet
CardioGuard tablets are classified as antiplatelet agents, commonly known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of heart attack or stroke in patients with cardiovascular disease. CardioGuard is also indicated for individuals recovering from a recent heart attack, experiencing severe angina (chest pain), or who have received coronary stents. Its use helps prevent further cardiac events, including recurrent heart attacks, strokes, and clot formation within stents. Concurrent use with aspirin, another antiplatelet medication, will likely be prescribed by your physician. CardioGuard can be ingested with or without food, but consistent daily dosing at the same time is crucial for effectiveness; discontinuing treatment significantly elevates the risk of subsequent cardiac events. The most prevalent side effect is increased bleeding; injuries may bleed more profusely and for longer periods. While usually mild and self-limiting, prolonged bleeding should be reported. Some patients experience mild shortness of breath, which generally subsides with continued therapy; however, worsening or persistent dyspnea warrants medical attention. CardioGuard is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Always disclose any such conditions to your doctor before commencing treatment.
Uses of Ticasign Tablet
Reducing the risk of cardiac arrest and cerebrovascular events
Major Benefits of Ticasign Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticasign Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Ticasign Tablet:
- Bleeding
- Breathlessness
How to use Ticasign Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Ticasign Tablet. The tablet should be swallowed whole; do not crush, chew, or break it. Ticasign Tablet can be taken with or without food, however, consistent timing is recommended.
How Ticasign Tablet works:
Ticagrelor tablets function as an antiplatelet agent, inhibiting platelet aggregation to reduce the risk of dangerous blood clot development, consequently minimizing the likelihood of cardiac infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Ticasign Tablet and alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Ticasign Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticasign Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticasign Tablet.
KidneySAFE IF PRESCRIBED
Ticasign Tablet poses no known safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Data regarding Ticasign Tablet use in patients undergoing renal dialysis is currently insufficient.
LiverCAUTION
Patients with liver impairment should use Ticasign Tablet cautiously, potentially requiring dose modification. Consult a physician before use. Ticasign Tablet is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Ticasign Tablet :
Should you forget a Ticasign Tablet dose, take it promptly. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing schedule. Never take a double dose.
Facts to Know About Ticasign Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
